AstraZeneca, Sanofi’s RSV therapy Beyfortus for infants shows ‘protection’ in trial Finances February 21, 2023 [ad_1] BeritK AstraZeneca (NASDAQ:AZN) and Sanofi’s (NASDAQ:SNY) antibody remedy Beyfortus continues to indicate constant safety towards Respiratory Syncytial Virus (RSV)…
